InsiderClue
Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

107
Insider
Date
Role
Action
Shares
Price
Amount
Karin Eastham
27 Oct 2026
Director
Sold after exercise
14,850
$50.00
$742.57K
Jens Holstein
27 Oct 2026
Director
Sold after exercise
7,500
$50.00
$375.00K
Jens Holstein
24 Sep 2026
Director
Sold after exercise
7,500
$47.00
$352.50K
Marc Stapley
4 Jun 2026
Chief Executive Officer
Sold after exercise
138,051
$50.12
$6.92M
Jonathan Wygant
22 May 2026
VP, Chief Accounting Officer
Sold after exercise
24,000
$45.40
$1.09M
Karin Eastham
5 Dec 2025
Director
Sold after exercise
800
$46.59
$37.27K
Karin Eastham
5 Dec 2025
Director
Sold after exercise
12,808
$45.84
$587.08K
Karin Eastham
5 Dec 2025
Director
Sold after exercise
6,392
$44.52
$284.57K
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
657
$46.38
$30.47K
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
24,296
$45.73
$1.11M
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
5,872
$45.07
$264.64K
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
10,837
$43.80
$474.70K
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
1,126
$43.03
$48.46K
Evan/ Fa Jones
5 Nov 2025
Director
Sold after exercise
408
$41.74
$17.03K
Robert S Epstein
1 Oct 2025
Director
Sold after exercise
21,473
$35.08
$753.20K
Karin Eastham
2 Jan 2025
Director
Sold after exercise
4,691
$40.50
$190.00K
Karin Eastham
2 Jan 2025
Director
Sold after exercise
5,309
$40.12
$213.01K
Robert S Epstein
12 Nov 2024
Director
Sold after exercise
15,000
$38.32
$574.83K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise indirect
912
$32.77
$29.88K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise indirect
22,407
$32.36
$725.03K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise indirect
3,869
$31.19
$120.65K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise
688
$32.77
$22.54K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise
16,838
$32.36
$544.85K
Evan/ Fa Jones
13 Aug 2024
Director
Sold after exercise
2,931
$31.19
$91.41K
Evan/ Fa Jones
9 Aug 2024
Director
Sold after exercise indirect
746
$30.03
$22.40K
Evan/ Fa Jones
9 Aug 2024
Director
Sold after exercise
1,032
$30.03
$30.99K
Evan/ Fa Jones
7 Aug 2024
Director
Sold after exercise
5,108
$30.32
$154.88K
Karin Eastham
7 Jun 2024
Director
Sold after exercise
2,500
$20.97
$52.43K
Karin Eastham
1 Apr 2024
Director
Sold after exercise
10,000
$21.65
$216.53K
Evan/ Fa Jones
1 Mar 2024
Director
Sold after exercise
10,000
$24.36
$243.60K
John L Bishop
18 Jul 2023
Director
Sold after exercise
10,000
$30.50
$305.00K
John L Bishop
17 Jul 2023
Director
Sold after exercise
10,000
$30.00
$300.00K
Bonnie H Anderson
14 Apr 2023
Director
Sold after exercise
34,000
$22.04
$749.36K
Karin Eastham
16 Mar 2023
Director
Sold after exercise
18,750
$22.78
$427.04K
Bonnie H Anderson
15 Mar 2023
Director
Sold after exercise
34,000
$22.76
$773.89K
Karin Eastham
28 Feb 2023
Director
Sold after exercise
10,000
$25.00
$250.00K
Bonnie H Anderson
17 Jan 2023
Director
Sold after exercise
4,494
$26.64
$119.73K
Bonnie H Anderson
17 Jan 2023
Director
Sold after exercise
29,506
$26.30
$776.11K
Bonnie H Anderson
11 Jan 2023
Director
Sold after exercise
63,247
$25.13
$1.59M
Bonnie H Anderson
1 Dec 2022
Executive Chairwoman
Sold after exercise
45,460
$28.60
$1.30M
Bonnie H Anderson
1 Dec 2022
Executive Chairwoman
Sold after exercise
34,540
$27.81
$960.45K
Giulia C Kennedy
11 Nov 2022
Chief Scientific & Med Officer
Sold after exercise
2
$29.34
$58.68
Giulia C Kennedy
5 Aug 2022
Chief Scientific & Med Officer
Sold after exercise
1,028
$26.54
$27.28K
Kevin K Gordon
8 Jun 2022
Director
Sold after exercise
15,000
$18.50
$277.50K
Giulia C Kennedy
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
100
$26.49
$2.65K
Giulia C Kennedy
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
5,844
$25.70
$150.19K
Giulia C Kennedy
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
17,059
$24.91
$424.94K
Karin Eastham
17 Dec 2021
Director
Sold after exercise
5,000
$45.00
$225.00K
Giulia C Kennedy
7 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
1,750
$41.55
$72.71K
Giulia C Kennedy
7 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
4,375
$39.69
$173.64K
Giulia C Kennedy
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
1,785
$37.26
$66.51K
Giulia C Kennedy
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
3,897
$36.11
$140.71K
Giulia C Kennedy
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
3,550
$35.37
$125.56K
Giulia C Kennedy
7 Sep 2021
Chief Scientific & Med Officer
Sold after exercise
497
$51.23
$25.46K
Giulia C Kennedy
7 Sep 2021
Chief Scientific & Med Officer
Sold after exercise
12,034
$50.52
$607.95K
Giulia C Kennedy
23 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
4,375
$39.75
$173.91K
Giulia C Kennedy
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
4,979
$35.17
$175.11K
Giulia C Kennedy
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
2,595
$34.39
$89.25K
Giulia C Kennedy
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
1,507
$33.28
$50.15K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
300
$55.49
$16.65K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
1,431
$54.72
$78.31K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,606
$53.50
$139.41K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
5,032
$52.38
$263.56K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
8,114
$51.38
$416.90K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,819
$50.40
$142.07K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,991
$49.22
$147.21K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
8,483
$48.29
$409.61K
Giulia C Kennedy
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
20,239
$47.11
$953.54K
Karin Eastham
25 Feb 2021
Director
Sold after exercise
200
$61.77
$12.35K
Karin Eastham
25 Feb 2021
Director
Sold after exercise
3,606
$61.09
$220.30K
Karin Eastham
25 Feb 2021
Director
Sold after exercise
2,444
$60.03
$146.71K
Bonnie H Anderson
13 Jan 2021
Chairman and CEO
Sold after exercise
12,177
$51.26
$624.18K
Bonnie H Anderson
13 Jan 2021
Chairman and CEO
Sold after exercise
6,364
$50.64
$322.28K
Bonnie H Anderson
12 Jan 2021
Chairman and CEO
Sold after exercise
400
$51.20
$20.48K
Bonnie H Anderson
12 Jan 2021
Chairman and CEO
Sold after exercise
15,568
$50.29
$782.98K
Bonnie H Anderson
12 Jan 2021
Chairman and CEO
Sold after exercise
4,386
$49.77
$218.31K
Bonnie H Anderson
11 Jan 2021
Chairman and CEO
Sold after exercise
11,497
$51.56
$592.75K
Bonnie H Anderson
11 Jan 2021
Chairman and CEO
Sold after exercise
34,257
$50.90
$1.74M
Bonnie H Anderson
11 Jan 2021
Chairman and CEO
Sold after exercise
25,351
$49.81
$1.26M
Kevin K Gordon
4 Jan 2021
Director
Sold after exercise
5,523
$49.27
$272.13K
Kevin K Gordon
4 Jan 2021
Director
Sold after exercise
4,477
$48.62
$217.66K
Giulia C Kennedy
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
6,094
$57.55
$350.73K
Giulia C Kennedy
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
4,279
$56.86
$243.28K
Giulia C Kennedy
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
3,642
$55.78
$203.14K
Kevin K Gordon
12 Nov 2020
Director
Sold after exercise
1,806
$47.85
$86.42K
Kevin K Gordon
12 Nov 2020
Director
Sold after exercise
8,194
$46.95
$384.72K
John Walter Hanna JR
6 Nov 2020
Chief Commercial Officer
Sold after exercise
1,200
$44.19
$53.03K
John Walter Hanna JR
6 Nov 2020
Chief Commercial Officer
Sold after exercise
20,050
$43.40
$870.08K
John Walter Hanna JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
133
$42.08
$5.60K
John Walter Hanna JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
2,660
$41.56
$110.55K
John Walter Hanna JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
3,613
$40.00
$144.51K
Bonnie H Anderson
8 Oct 2020
Chairman and CEO
Sold after exercise
50,000
$38.00
$1.90M
Giulia C Kennedy
6 Oct 2020
Chief Scientific & Med Officer
Sold after exercise
2,500
$35.21
$88.03K
Bonnie H Anderson
10 Sep 2020
Chairman and CEO
Sold after exercise
6,607
$31.47
$207.93K
Bonnie H Anderson
10 Sep 2020
Chairman and CEO
Sold after exercise
13,393
$30.61
$409.93K
Giulia C Kennedy
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,141
$32.24
$69.02K
Giulia C Kennedy
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,350
$31.21
$73.34K
Giulia C Kennedy
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,536
$30.05
$76.21K
John Walter Hanna JR
31 Aug 2020
Chief Commercial Officer
Sold after exercise
473
$33.78
$15.98K
John Walter Hanna JR
31 Aug 2020
Chief Commercial Officer
Sold after exercise
55,970
$33.37
$1.87M
John Walter Hanna JR
21 Aug 2020
Chief Commercial Officer
Sold after exercise
1,400
$36.00
$50.41K
Giulia C Kennedy
31 Jul 2020
Chief Scientific & Med Officer
Sold after exercise
20,000
$35.33
$706.69K
John Walter Hanna JR
31 Jul 2020
Chief Commercial Officer
Sold after exercise
14,095
$36.12
$509.15K
Bonnie H Anderson
30 Jul 2020
Chairman and CEO
Sold after exercise
11,365
$32.24
$366.40K
Bonnie H Anderson
23 Jul 2020
Chairman and CEO
Sold after exercise
3,280
$32.04
$105.11K
Bonnie H Anderson
22 Jul 2020
Chairman and CEO
Sold after exercise
100
$32.00
$3.20K
Bonnie H Anderson
21 Jul 2020
Chairman and CEO
Sold after exercise
3,447
$32.09
$110.61K
Showing 250 of 387 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 497
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 86
Sales straight out of an exercise 195
Sales at will 77
Transactions with no price 1
Shares from compensation/vesting 7,403,527
Sales filed before the plan box existed 64
History held since 4 Nov 2013